people with type I, type II diabetes or other types of diabetes (e.g. The sensor and transmitter are fixed to the upper arm and the receiver shows current blood glucose level and a graph of recent blood glucose levels.Ī continuous glucose monitor (CGM) is a device used for monitoring blood glucose on a continual basis by insulin-requiring people with diabetes, e.g.
Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technol Ther 2000 2(3):461-72.Abbott Laboratories' FreeStyle CGM. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada: monitoring glycemic control. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Development of the likelihood of low glucose (LLG) algorithm for evaluating risk of hypoglycemia: A new approach for using continuous glucose data to guide therapeutic decision making.
Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes 2013 37(2):82-89.ġ0. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Standards of medical care in diabetes, 2014. Last updated August 2019.ħ. American Diabetes Association. Last updated July 2016.Ħ. National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. J Med Econ 2014 17(3):167-75.ĥ. National Institute for Health and Care Excellence. Frequency of blood glucose testing among insulin-treated diabetes mellitus patients in the United Kingdom. Consensus statement on self-monitoring of blood glucose in diabetes. Invasiveness as a barrier to self-monitoring of blood glucose in diabetes. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. †† Includes percentage of values <3.0 mmol/L.ġ. Vincze G, et al. ** Includes percentage of values >13.9 mmol/L. ¶ The international consensus report has been endorsed by the American Diabetes Association, American Association of Clinical Endocrinologists, American Association of Diabetes Educators, European Association for the Study of Diabetes, Foundation of European Nurses in Diabetes, International Society for Pediatric and Adolescent Diabetes, JDRF, and Pediatric Endocrine Society.
Study data are applicable to both products. FreeStyle Libre 2 has the same features as the FreeStyle Libre System, with the addition of optional real-time glucose alarms. § Data collected from the FreeStyle Libre System. ‡ Treatment decisions should not be based on real-time sensor glucose readings alone but instead should consider all the information on the results screen. † FreeStyle Libre 2 users: Finger pricks are required if your glucose readings and alarms do not match symptoms or expectations. * FreeStyle Libre users: A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycemia or impending hypoglycemia is reported by the FreeStyle LibreLink app or when symptoms do not match the app readings.